Workflow
Retail Investors' Top Stocks With Earnings This Week: Micron, BlackBerry And More
Benzinga· 2025-09-23 00:36
Individual investors are preparing for the week ahead, with several high-stakes earnings reports on the calendar.  Here’s a look at some of the companies reporting this week that retail traders will be watching, including Micron Technology, Inc. MU and Uranium Energy Corp. UEC. MU stock is up 40% over the past month. See the real-time price action here. Tuesday, Sept. 23: MicronMicron is set to release its fourth-quarter earnings report after Tuesday’s closing bell in what will likely be the most-watched re ...
Earnings This Week: Micron's Moment, Costco On Deck
Benzinga· 2025-09-23 00:36
Two very different stories… one riding the AI wave, the other proving steady compounding still wins.The market is watching two giants this week. Micron Technology MU tests whether memory has entered a new supercycle, while  Costco COST gives us a read on the consumer and the power of recurring membership economics. Micron… How is it Up 78% YTD?Micron heads into earnings after the close on Tuesday riding a powerful AI-memory wave. Shares have ripped this year on surging demand for HBM3E attached to Nvidia’s  ...
Barrick hits 13-year high as analysts upgrade stock on ‘game-changing’ discovery
MINING.COM· 2025-09-23 00:35
Barrick Mining (NYSE: B) (TSX: ABX) rallied to its highest in 13 years, as it builds off the momentum of a “game-changing” gold find in Nevada as well as the broader strength of the precious metals market.The miner’s Toronto-listed shares shot up by as much as 6% to C$49.33 apiece, its best since early 2012. Its New York-listed shares followed similar moves, with an intraday high of $35.70. The company’s market capitalizations on the respective markets are C$81.7 billion and $59.6 billion.Barrick’s TSX-list ...
Fidus Investment: I'm Buying This Overlooked 11% Yield (NASDAQ:FDUS)
Seeking Alpha· 2025-09-23 00:35
iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.Successful investing doesn't have to be a popularity contest, and for good reason. That's because favored names by the market often come with lofty valuation ...
Fidus Investment: I'm Buying This Overlooked 11% Yield
Seeking Alpha· 2025-09-23 00:35
iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.Successful investing doesn't have to be a popularity contest, and for good reason. That's because favored names by the market often come with lofty valuation ...
T-Mobile's new CEO Srini Gopalan faces pressure to fend off rivals
Yahoo Finance· 2025-09-23 00:33
T-Mobile (TMUS) is handing the CEO baton to Srini Gopalan, the company's COO, as the carrier braces to fend off rivals in wireless and broadband. Gopalan, who will succeed Mike Sievert on Nov. 1 after the CEO's five-year run, said he is "honored and grateful" for the opportunity to build on Sievert's legacy of "disrupting the industry" while pushing further into artificial intelligence and digital capabilities. T-Mobile stock was little changed in Monday trading. Year to date, the stock is up over 7% and ...
Apple CEO Tim Cook Just Revealed 1 Little-Known Tech Stock for Investors to Snatch Up Here
Yahoo Finance· 2025-09-23 00:33
Shares of Outsourced Semiconductor Assembly & Test (OSAT) provider Amkor Technology (AMKR) shot up when iPhone-maker Apple's (AAPL) CEO Tim Cook mentioned the company in a recent interview with CNBC's Mad Money. Highlighting Amkor's importance as a packaging partner of the company, Cook stated, “And then, you know, it goes to GlobalWafers, a company that’s in Texas, and they will serve companies like TSMC (TSM), which will do that, provide the fab for the product, for the chips, and then Amkor, another com ...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRO and SMLR on Behalf of Shareholders
Prnewswire· 2025-09-23 00:32
Accessibility StatementSkip Navigation NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PROS Holdings, Inc. (NYSE: PRO)'s sale to Thoma Bravo for $23.25 per share in cash. If you are a PROS shareholder, click here to learn more about your rights and options. Semler Scientific, Inc. (NASDAQ: SMLR)'s sale to ...
Exor: Solid NAV Per Share Growth, Firepower For New Deals
Seeking Alpha· 2025-09-23 00:32
In our previous analysis, we compared Exor N.V. ( OTCPK:EXXRF ) and Porsche Automobil Holding SE, with a preference for the Italian/Dutch holding, and we continue to hold this view. The group reported its half-year results recently, showingBuy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they m ...
FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing
ZACKS· 2025-09-23 00:31
Key Takeaways SNY's NDA for tolebrutinib in nrSPMS is under FDA priority review with a decision pushed to Dec. 28, 2025.Extension follows submission of new analyses, deemed a major amendment to SNY's application by the FDA.In phase III studies, tolebrutinib delayed confirmed disability progression versus placebo and Aubagio.Sanofi (SNY) announced that the FDA has extended the target action date for its new drug application (NDA) for tolebrutinib by three months. The NDA is seeking approval of tolebrutinib, ...